Username

Enter your Progress In Mind Portugal username.

Password

Enter the password that accompanies your username.

Request new password

Progress in Mind Portugal

Topics
Congress highlights
- EAN 2022
- AAN 2022
- AHS 2022
- AAN 2021
- AHS 2021
- IHC 2021
- SIRS 2019
- EPA 2019
- EPA 2018
- APA 2018
- ECNP 2017
About
Podcasts
Newsletter signup

Search

Main navigation

Home
Lundbeck Therapeutic Area Australia
Progress in Mind Korea Focus Area
Progress in Mind Spain Focus Area
전문가 칼럼
찾아보기

Tools

찾아보기
User Profile

User account menu

Username

Password

Reset your password

The information on this site is exclusively intented for health care professionals.

Accept Decline

Depression 12 May, 2023 Read Time: 1 min

Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM?

Saiba mais sobre a experiência do Professor Andrea Fagiolini com a dose de 20 mg no webinar que se segue.

Schizophrenia

Satellite symposium

Improving treatment outcomes in schizophrenia: Looking beyond positive symptoms for early and effective intervention

Schizophrenia

Congress highlights

Can people with ultra-high risk of psychosis benefit from cognitive remediation?

Migraine

Congress highlights

Focus on general migraine burden and during pregnancy in Arab countries

Social Networks

Progress in Mind Portugal HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Portugal click here.

Continue to verification page Login with email

Brought to you by

PROGRESS IN MIND PORTUGAL

Condições de Utilização

subscribe newsletter

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue

By submitting this form you agree that your email is sent to a third party for validation.

Read the full terms and conditions here.